Stock Alert: Medigus Soars 70%

By RTTNews Staff Write  ✉   | Published:

Shares of nano-cap company Medigus Ltd. (MDGS) surged over 70% on Tuesday morning. MDGS is currently trading at $3.24, up $1.35 or 71.43%, on the Nasdaq.

Medigus, a medical device company, develops, produces, and markets minimally invasive endo-surgical tools and direct visualization technology in the United States, Europe, Asia, and internationally.

Medigus announced that it was informed by Smart Repair Pro, Inc. a data-driven e-commerce company operating on the Amazon Marketplace, that all of Amazon's required regulatory processes were completed, which allows for the opening of its store in 5 leading countries: UK, France, Italy, Germany and Spain.

Smart Repair Pro is preparing to launch its brands for the first time in the European and UK market.

Last week, Medigus agreed to buy a controlling interest in Smart Repair Pro, Inc. and Purex, Inc., two data-driven e-commerce companies, operating on the Amazon Marketplace.

According to initial information provided to Medigus, the companies' revenues target for 2020 is about $3 million with net profit of around 35%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Condiments maker Sauer Brands, Inc. is recalling The Spice Hunter Products for potential contamination with Salmonella, according to a statement by the U.S. Food and Drug Administration or FDA. The spice and seasoning products are being recalled after the company was notified by its supplier of the potential presence of salmonella in specific lots of organic parsley supplied by them. Amazon Prime Day, the e-commerce giant's two-day shopping event, commences today in 19 countries worldwide that runs for 48 hours. In the U.S., the company's biggest shopping event of the year kickstarted at 3 am ET. During these two full days of shopping, Prime members will have exclusive access to more than one million deals across every category from toys, electronics, fashion, Amazon devices.. Healthcare company Johnson & Johnson on Tuesday reported that its profit for third quarter that more than doubled from last year, powered by better-than-expected procedure recovery in medical devices, growth in consumer health, and continued strength in pharmaceuticals. Both adjusted earnings per share and revenues topped analysts' expectations.The company also boosted its full-year 2020 outlook.